Boston Head & Neck Cancer Symposium

Register now for the Boston Head and Neck Cancer Symposium

Register Now

Agenda

Time	Session / Presenter
7:30 – 8:00 a.m.	Registration
8:00 – 8:10 a.m.	Welcome & Opening Remarks
Session 1 8:10 – 9:30 a.m.	Head and Neck Cancer: A Look into the Future *Session Chair: Robert Haddad, MD* Chief, Division of Head and Neck Oncology McGraw Chair in Head and Neck Oncology Dana Farber Cancer Institute Professor of Medicine Harvard Medical School
8:10 – 8:30 a.m.	Novel agents and mechanisms for recurrent/metastatic disease Alan Ho, MD, PhD Chief of Head and Neck Medical Oncology Memorial Sloan Kettering Cancer Center
8:30 – 8:50 a.m.	Salivary Gland Tumors: Molecular Characterization and Therapeutic Advances for Metastatic Disease Renata Ferrarotto, M.D. Professor, Thoracic Head and Neck Medical Oncology University of Texas M.D. Anderson Cancer Center
8:50 – 9:10 a.m.	A picture is worth a thousand data points: AI and imaging for head and neck cancers Benjamin Kann, MD Physician Brigham and Women’s Hospital \| Dana-Farber Cancer Institute Associate Professor of Radiation Oncology Harvard Medical School Faculty, Mass General Brigham Artificial Intelligence in Medicine (AIM) Program
9:10 – 9:30 a.m.	Panel Discussion
9:30 – 10:15 a.m.	*Keynote Presentation – Tumor and blood based predictive biomarkers of response to immunotherapy in HNSCC* Lillian L Siu, MD, FRCPC Professor, University of Toronto Medical Oncologist Director, Phase I Program BMO Chair in Precision Genomics Princess Margaret Cancer Centre
10:15 – 10:35 a.m.	Coffee Break
Session 2 10:35 – 11:55 a.m.	Targeting Head & Neck Cancer Complexity Session Chair: Maria Kukuruzinska, PhD Professor and Chair, Department of Translational Dental Medicine Associate Dean for Research Boston University School of Dental Medicine
10:35 – 10:55 a.m.	The impact of Aging on Immune Evasive Carcinoma Cell States in Head and Neck Cancer Xaralabos (Bob) Varelas, PhD Professor, Biochemistry and Cell Biology Boston University Chobanian & Avedisian School of Medicine
10:55 – 11:15 a.m.	Serine Metabolism Epigenetically Directs The Evolution of Oral Squamous Cell Carcinoma Glenn Hanna, MD Director, Center for Cancer Therapeutic Innovation Director, Center for Salivary and Rare Head and Neck Cancers Dana Farber Cancer Institute Associate Professor of Medicine, Harvard Medical School
11:15 – 11:35 a.m.	Exploiting Head and Neck Cancer Oncosignaling Circuitries in the Era of Precision Medicine: Novel Multimodal Targeted and Immunotherapies J. Silvio Gutkind, Ph.D. American Cancer Society (ACS) Research Professor Distinguished Professor & Chair Department of Pharmacology, School of Medicine Associate Director Basic Science, Moores Cancer Center University of California, San Diego
11:35 – 11:55 a.m.	Panel Discussion
11:55 a.m. – 12:15pm	Patient Presentation and Discussion *Session Chair: Michael Dennis, MD* Physician, Center for Head and Neck Oncology, Dana-Farber Cancer Institute Instructor in Medicine, Harvard Medical School Shawn Elizabeth George Head & Neck Cancer Survivor and Advocate
12:15 – 1 p.m.	Lunch
1 – 1:45 p.m.	*Keynote Presentation 2 – Evolving landscape of perioperative immunotherapy in head and neck cancer* Ravindra Uppaluri, MD, PhD Chief, Head and Neck Surgical Oncology Chief, Division of Otolaryngology Distinguished Chair in Otolaryngology Brigham and Women’s Hospital and Dana-Farber Cancer Institute Associate Professor of Otolaryngology, Harvard Medical School
Session 3 1:45 – 3:05 p.m.	Technological Advances in Head and Neck Cancer Management *Session Chair: Derrick Lin, MD, FACS* Associate Chief of the Department of Otolaryngology–Head and Neck; Physician and Surgeon Massachusetts Eye and Ear Daniel Miller Professor of Otolaryngology–Head and Neck Surgery Harvard Medical School
1:45 – 2:05 p.m.	ctDNA for MRD detection in head and neck cancer Dan Faden, MD FACS Assistant Professor, Harvard Medical School Department of Otolaryngology-Head and Neck Surgery Attending Surgeon, Mass Eye and Ear and Mass General Hospital Associate Scientist, Broad Institute of MIT and Harvard Principal Investigator, Mike Toth Head and Neck Cancer Center
2:05 – 2:25 p.m.	Advances in Transoral Robotic Surgery and the Status of de-escalation in Oropharyngeal Cancer Management Rosh K. Sethi, MD, MPH Assistant Professor of Otolaryngology–Head and Neck Surgery, Harvard Medical School Associate Surgeon, Brigham and Women’s Hospital Jeremy D. Richmon, MD Associate Professor of Otolaryngology–Head and Neck Surgery, Harvard Medical School Director, Head and Neck Robotic Surgery, Mass Eye and Ear
2:25 – 2:45 p.m.	Advances in Management of Complex Head and Neck Defects-Optimizing Functional Outcomes Allen L. Feng, MD Assistant Professor, Harvard Medical School Head & Neck Oncology, Microvascular Reconstruction Chief of Otolaryngology, Salem Hospital Surgical Director of Head & Neck Cancer, MGH North Shore Cancer Center Massachusetts Eye and Ear Heather Edwards, MD Director, Division of Head and Neck Surgery Department of Otolaryngology – Head and Neck Surgery Boston Medical Center Associate Professor Boston University Chobanian & Avedisian School of Medicine
2:45 – 3:05 p.m.	Panel Discussion

Boston Head & Neck Cancer Symposium

Register Now

Agenda

Objectives

Sponsors

Contact

Price/Credits